Results 111 to 120 of about 8,601 (210)

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma. [PDF]

Cancers (Basel)
Martino M, Marafioti V, Pitea M, Porto G, Policastro G, Canale FA, Naso V, Alati C.   +7 more
europepmc   +1 more source

Indirect Treatment Comparisons of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in Third-Line or Later Relapsed or Refractory Follicular Lymphoma. [PDF]

Adv Ther
Boardman AP, Reguera Ortega JL, Wang P, Bar M, Kumar J, Farazi T, Martín García-Sancho A, Izutsu K.   +7 more
europepmc   +1 more source

Comparative pharmacokinetic derivations for axicabtagene ciloleucel and brexucabtagene autoleucel in the treatment of B cell malignancies. [PDF]

Mol Ther Adv
Salunkhe SS, Nater J, Schweitzer C, Mao D, Dong J, Venkkataram R, Xue A, Filosto S, Mattie M, Shen RR.   +9 more
europepmc   +1 more source

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients. [PDF]

Eur J Haematol
Sainatham C, Goloubeva O, Margiotta P, Alharthy H, Patel I, Gaddipati G, Bukhari A, Law J, Lee ST, Kocoglu M, Yared J, Hardy N, Nelson M, Ahmed N, Mushtaq MU, McGuirk J, Rapoport AP, Dahiya S, Lutfi F.   +18 more
europepmc   +1 more source

Isolation and Characterisation of Phage-Displayed scFv Antibodies Targeting PfHSP70 and PfLDH of <i>Plasmodium falciparum</i>. [PDF]

Biochem Res Int
Gasa NL, Zuma LK, Chiliza TE, Kwezi L, Luthuli SD, Pooe OJ.   +5 more
europepmc   +1 more source

Ziba Jiyane and Jacob Zuma

443-Fo-3-91.jpg created from original photograph in the IDASA Collection held in the Manuscripts Section of the Stellenbosch Library and Information Service.IFP member Ziba Jiyane (left) and ANC member Jacob Zuma ...

core  

CD19 CAR-T cell therapy in large B-cell lymphoma: clinical evidence, resistance, toxicity, and precision strategies. [PDF]

Front Immunol
Wang C, Zhu J, Qiao J, Wang H, Liang X.
europepmc   +1 more source

Response to Methodological Concerns Regarding Eligibility Criteria and Study Selection in a Systematic Review and Meta-Analysis of CAR T-Cell Therapy for Hematologic Malignancies. [PDF]

Am J Hematol
Filippatos C, Ntanasis-Stathopoulos I, Terpos E.   +2 more
europepmc   +1 more source

Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial. [PDF]

Clin Cancer Res
Jacobson CA, Westin JR, Miklos DB, Herrera AF, Ritz J, Rodig S, Arihara Y, Cao S, Sun J, Mao D, Adhikary S, Neumann F, Grechko N, Locke FL.   +13 more
europepmc   +1 more source

Quality of Life in CAR-T Cell Therapy. [PDF]

Hematol Rep
Alati C, Pitea M, Porto G, Policastro G, Bilardi E, Utano G, Giordano L, Sgarlata A, Delfino IM, Idato A, Santoro G, Canale FA, Naso V, Martino M.   +13 more
europepmc   +1 more source